Annual Cash & Cash Equivalents
$200.35 M
+$111.85 M+126.39%
December 31, 2023
Summary
- As of February 22, 2025, WVE annual cash & cash equivalents is $200.35 million, with the most recent change of +$111.85 million (+126.39%) on December 31, 2023.
- During the last 3 years, WVE annual cash & cash equivalents has risen by +$15.85 million (+8.59%).
- WVE annual cash & cash equivalents is now at all-time high.
Performance
WVE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$310.95 M
+$156.99 M+101.97%
September 30, 2024
Summary
- As of February 22, 2025, WVE quarterly cash and cash equivalents is $310.95 million, with the most recent change of +$156.99 million (+101.97%) on September 30, 2024.
- Over the past year, WVE quarterly cash and cash equivalents has increased by +$110.60 million (+55.20%).
- WVE quarterly cash and cash equivalents is now at all-time high.
Performance
WVE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
WVE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +126.4% | +55.2% |
| 3 y3 years | +8.6% | +55.2% |
| 5 y5 years | +14.6% | +55.2% |
WVE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +126.4% | at high | +403.9% |
| 5 y | 5-year | at high | +126.4% | at high | +403.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Wave Life Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $310.95 M(+102.0%) |
| Jun 2024 | - | $153.96 M(-14.9%) |
| Mar 2024 | - | $180.92 M(-9.7%) |
| Dec 2023 | $200.35 M(+126.4%) | $200.35 M(+43.2%) |
| Sep 2023 | - | $139.94 M(-19.1%) |
| Jun 2023 | - | $172.97 M(-16.7%) |
| Mar 2023 | - | $207.56 M(+134.5%) |
| Dec 2022 | $88.50 M(-41.2%) | $88.50 M(-8.7%) |
| Sep 2022 | - | $96.95 M(-21.3%) |
| Jun 2022 | - | $123.16 M(+99.6%) |
| Mar 2022 | - | $61.71 M(-59.0%) |
| Dec 2021 | $150.56 M(-18.4%) | $150.56 M(+21.5%) |
| Sep 2021 | - | $123.90 M(-13.9%) |
| Jun 2021 | - | $143.84 M(-3.2%) |
| Mar 2021 | - | $148.53 M(-19.5%) |
| Dec 2020 | $184.50 M(+25.4%) | $184.50 M(-14.7%) |
| Sep 2020 | - | $216.36 M(+130.0%) |
| Jun 2020 | - | $94.05 M(-22.2%) |
| Mar 2020 | - | $120.95 M(-17.8%) |
| Dec 2019 | $147.16 M | $147.16 M(-29.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $209.01 M(-17.4%) |
| Jun 2019 | - | $252.91 M(-12.1%) |
| Mar 2019 | - | $287.57 M(+64.5%) |
| Dec 2018 | $174.82 M(+22.7%) | $174.82 M(-16.9%) |
| Sep 2018 | - | $210.49 M(-12.8%) |
| Jun 2018 | - | $241.43 M(+118.5%) |
| Mar 2018 | - | $110.49 M(-22.5%) |
| Dec 2017 | $142.50 M(-5.2%) | $142.50 M(-15.4%) |
| Sep 2017 | - | $168.46 M(-14.7%) |
| Jun 2017 | - | $197.39 M(+52.4%) |
| Mar 2017 | - | $129.48 M(-13.8%) |
| Dec 2016 | $150.29 M(-6.8%) | $150.29 M(-11.1%) |
| Sep 2016 | - | $169.01 M(-7.0%) |
| Jun 2016 | - | $181.76 M(+18.5%) |
| Mar 2016 | - | $153.40 M(-4.9%) |
| Dec 2015 | $161.22 M(>+9900.0%) | $161.22 M(+144.1%) |
| Sep 2015 | - | $66.04 M(+749.0%) |
| Jun 2015 | - | $7.78 M(+642.3%) |
| Dec 2014 | $1.05 M(+138.7%) | $1.05 M |
| Dec 2013 | $439.00 K | - |
FAQ
- What is Wave Life Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Wave Life Sciences?
- What is Wave Life Sciences annual cash & cash equivalents year-on-year change?
- What is Wave Life Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Wave Life Sciences?
- What is Wave Life Sciences quarterly cash and cash equivalents year-on-year change?
What is Wave Life Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of WVE is $200.35 M
What is the all time high annual cash & cash equivalents for Wave Life Sciences?
Wave Life Sciences all-time high annual cash & cash equivalents is $200.35 M
What is Wave Life Sciences annual cash & cash equivalents year-on-year change?
Over the past year, WVE annual cash & cash equivalents has changed by +$111.85 M (+126.39%)
What is Wave Life Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of WVE is $310.95 M
What is the all time high quarterly cash and cash equivalents for Wave Life Sciences?
Wave Life Sciences all-time high quarterly cash and cash equivalents is $310.95 M
What is Wave Life Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, WVE quarterly cash and cash equivalents has changed by +$110.60 M (+55.20%)